Drreddys Laboratories | Des Atouts



Assets Changement Date
ANI Pharmaceuticals USD 1.28B 3.68M 2024-12
Aurora Cannabis CAD 866.52M 57.75M 2024-12
Bayer EUR 110.85B 3.9B 2024-12
Canopy Growth CAD 1.16B 68.13M 2024-12
Cipla INR 346.55B 19.37B 2024-09
Corcept Therapeutics USD 840.55M 56.3M 2024-12
Drreddys Laboratories INR 481.06B 15.1B 2024-12
GlaxoSmithKline GBP 60.71B 1.24B 2025-03
Hikma Pharmaceutical USD 4.85B 167M 2024-06
Lonza CHF 19.73B 1.85B 2024-12
Novartis USD 102.25B 1.28B 2024-12
Pacira USD 1.55B 31.82M 2024-12
Prestige Brands USD 3.33B 12.61M 2024-12
Richter Gedeon HUF 1.6T 116.26B 2024-12
Sun Pharmaceuticals INR 881.16B 26.53B 2024-09
Supernus Pharmaceuticals USD 1.37B 25.37M 2024-12
Teva Pharmaceutical Industries USD 39.33B 2.43B 2024-12



Drreddys Laboratories Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.